Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 17/20 | 0.72 |
| ▸ | TMIGD3 | P0DMS9 | 3/20 | 0.72 |
| ▸ | HTR2B | P41595 | 2/20 | 0.72 |
| ▸ | ADORA1 | P30542 | 7/20 | 0.68 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.64 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29573481 | 0.87 | ADORA3 (0.70) | ADORA3TMIGD3HTR2BADORA1SLC6A3 | |
| SCHEMBL29574457 | 0.85 | ADORA3 (0.54) | ADORA3TMIGD3HTR2BADORA1SLC6A3 | |
| SCHEMBL21779323 | 0.84 | ADORA3 (1.00) | ADORA3TMIGD3HTR2BADORA1SLC6A3 | |
| SCHEMBL21779354 | 0.84 | ADORA3 (1.00) | ADORA3TMIGD3HTR2BADORA1SLC6A3 | |
| SCHEMBL21779294 | 0.84 | ADORA3 (1.00) | ADORA3TMIGD3HTR2BADORA1SLC6A3 | |
| SCHEMBL16774252 | 0.84 | ADORA3 (1.00) | ADORA3TMIGD3HTR2BADORA1SLC6A3 | |
| SCHEMBL16774370 | 0.81 | ADORA3 (1.00) | ADORA3TMIGD3ADORA1 | |
| SCHEMBL25566685 | 0.81 | ADORA3 (0.82) | ADORA3TMIGD3ADORA1HSP90B1 | |
| SCHEMBL16774258 | 0.81 | ADORA3 (1.00) | ADORA3TMIGD3ADORA1 | |
| SCHEMBL29575011 | 0.81 | ADORA3 (0.70) | ADORA3TMIGD3HTR2BADORA1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116457356-A | A3 adenosine receptor agonists for use in medicine | 生物干预公司 | 2023-07-18 | — | — | CN | disclosed |
| EP-4196219-A1 | A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE | Biointervene, Inc. (US) | 2023-06-21 | — | — | EP | disclosed |
| WO-2022040241-A1 | A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE | BIOINTERVENE, INC. (US) | 2022-02-24 | — | — | WO | disclosed |